# POU6F2

## Overview
POU6F2 is a gene that encodes the POU class 6 homeobox 2 protein, a transcription factor involved in the regulation of gene expression during the development and differentiation of various tissues. This protein is characterized by its POU-specific and homeobox domains, which facilitate its binding to specific DNA sequences, thereby influencing the transcription of target genes. POU6F2 plays a critical role in the differentiation of human corneal endothelial cells and is implicated in the development of the nervous system and kidneys. It is also known as Retina-derived POU domain factor 1 (RPF-1) due to its significant expression in the retina, where it contributes to the differentiation of retinal cells. The gene's involvement in various developmental processes and its potential role as a tumor suppressor highlight its clinical significance, particularly in conditions such as prolactinomas, Wilms tumors, and idiopathic hypogonadotropic hypogonadism (Fiorino2016Retinaderived; Cho2023POU6F2; Perotti2004Germline).

## Structure


## Function
The POU6F2 gene encodes a transcription factor that plays a significant role in the differentiation and development of various tissues, particularly in the human corneal endothelial cells (CECs) and the nervous system. In CECs, POU6F2 is specifically expressed and is associated with the differentiation and maturation of these cells. It is predominantly found in differentiated and mature CECs, suggesting its involvement in the terminal differentiation process of these cells, which is crucial for maintaining corneal transparency (Yoshihara2017Restricted).

POU6F2 is also implicated in the development of the kidney and nervous system. It is expressed during kidney embryogenesis and is involved in regulating genes important for kidney development and neuronal specification (Fiorino2016Retinaderived; Renzo2006The). The gene's expression in the central nervous system, particularly in the retina, suggests a role in the initial steps of retinal differentiation, influencing the commitment of amacrine and ganglion cells (Perotti2004Germline). POU6F2's activity in the nucleus involves binding to specific DNA sequences to modulate the transcription of target genes, thereby influencing cell fate and function (Fiorino2016Retinaderived).

## Clinical Significance
Mutations and alterations in the POU6F2 gene have been implicated in several diseases and conditions. In prolactinomas, a type of pituitary adenoma, novel somatic mutations in POU6F2 have been identified. These mutations are associated with decreased expression of the gene, leading to increased cell proliferation and prolactin secretion, suggesting that POU6F2 acts as a tumor suppressor in this context (Miao2019Identification).

In Wilms tumors, a pediatric kidney malignancy, germline mutations in POU6F2 have been linked to loss of heterozygosity on chromosome 7p14. These mutations suggest a potential role for POU6F2 as a tumor suppressor gene, contributing to hereditary predisposition to Wilms tumors (Perotti2004Germline).

POU6F2 mutations have also been associated with idiopathic hypogonadotropic hypogonadism (IHH), a condition characterized by absent pubertal development. Specific mutations in POU6F2 disrupt its role as a transcriptional regulator of GnRH1, leading to altered GnRH transcript expression and contributing to the pathogenesis of IHH (Cho2023POU6F2).

Additionally, POU6F2 has been linked to glaucoma risk, as it modulates central corneal thickness, a significant risk factor for the disease. Although associations with glaucoma have been observed, they have not reached statistical significance, indicating the need for further research (King2018Genomic).

## Interactions
POU6F2, also known as Retina-derived POU domain factor 1 (RPF-1), is a transcription factor that interacts with DNA through its POU-specific and homeobox domains. It has been shown to bind specifically to DNA motifs, including POU consensus sites and SOX/POU composite motifs, which are crucial for its role in transcriptional activation (Fiorino2016Retinaderived). The DNA-binding activity of POU6F2 is influenced by a Ser-rich region upstream of the POU domain, which is essential for efficient binding (Fiorino2016Retinaderived).

POU6F2 can form complexes with other transcription factors, such as SOX proteins, to mediate transcriptional activity by binding to combined POU/SOX sequences (Fiorino2016Retinaderived). This interaction suggests a role in modulating gene expression during developmental processes. Electrophoretic mobility shift assays (EMSA) have demonstrated the binding of POU6F2 to specific DNA motifs, confirming its interaction with nucleic acids (YOSHIDA2014Molecular).

The protein also interacts with components of the Polycomb repressor complex 2 (PRC2), although direct interactions have not been confirmed by co-immunoprecipitation (Fiorino2016Retinaderived). These interactions highlight POU6F2's involvement in regulating gene expression relevant to renal and neuronal development.


## References


[1. (Perotti2004Germline) Daniela Perotti, Giovanna De Vecchi, Maria A. Testi, Elena Lualdi, Piergiorgio Modena, Patrizia Mondini, Fernando Ravagnani, Paola Collini, Francesca Di Renzo, Filippo Spreafico, Monica Terenziani, Gabriella Sozzi, Franca Fossati-Bellani, and Paolo Radice. Germline mutations of thepou6f2 gene in wilms tumors with loss of heterozygosity on chromosome 7p14. Human Mutation, 24(5):400–407, 2004. URL: http://dx.doi.org/10.1002/humu.20096, doi:10.1002/humu.20096. This article has 33 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.20096)

[2. (Yoshihara2017Restricted) Masahito Yoshihara, Susumu Hara, Motokazu Tsujikawa, Satoshi Kawasaki, Yoshihide Hayashizaki, Masayoshi Itoh, Hideya Kawaji, and Kohji Nishida. Restricted presence of pou6f2 in human corneal endothelial cells uncovered by extension of the promoter-level expression atlas. EBioMedicine, 25:175–186, November 2017. URL: http://dx.doi.org/10.1016/j.ebiom.2017.10.024, doi:10.1016/j.ebiom.2017.10.024. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ebiom.2017.10.024)

[3. (Fiorino2016Retinaderived) Antonio Fiorino, Giacomo Manenti, Beatrice Gamba, Gabriele Bucci, Loris De Cecco, Michele Sardella, Giacomo Buscemi, Sara Ciceri, Maria T. Radice, Paolo Radice, and Daniela Perotti. Retina-derived pou domain factor 1 coordinates expression of genes relevant to renal and neuronal development. The International Journal of Biochemistry &amp; Cell Biology, 78:162–172, September 2016. URL: http://dx.doi.org/10.1016/j.biocel.2016.07.013, doi:10.1016/j.biocel.2016.07.013. This article has 10 citations.](https://doi.org/10.1016/j.biocel.2016.07.013)

[4. (Renzo2006The) Francesca Di Renzo, Luisa Doneda, Elena Menegola, Michele Sardella, Giovanna De Vecchi, Paola Collini, Filippo Spreafico, Franca Fossati-Bellani, Erminio Giavini, Paolo Radice, and Daniela Perotti. The murine pou6f2 gene is temporally and spatially regulated during kidney embryogenesis and its human homolog is overexpressed in a subset of wilms tumors. Journal of Pediatric Hematology/Oncology, 28(12):791–797, December 2006. URL: http://dx.doi.org/10.1097/MPH.0b013e31802d3e65, doi:10.1097/mph.0b013e31802d3e65. This article has 13 citations.](https://doi.org/10.1097/MPH.0b013e31802d3e65)

[5. (King2018Genomic) Rebecca King, Felix L. Struebing, Ying Li, Jiaxing Wang, Allison Ashley Koch, Jessica N. Cooke Bailey, Puya Gharahkhani, Stuart MacGregor, R. Rand Allingham, Michael A. Hauser, Janey L. Wiggs, and Eldon E. Geisert. Genomic locus modulating corneal thickness in the mouse identifies pou6f2 as a potential risk of developing glaucoma. PLOS Genetics, 14(1):e1007145, January 2018. URL: http://dx.doi.org/10.1371/journal.pgen.1007145, doi:10.1371/journal.pgen.1007145. This article has 25 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1007145)

[6. (Cho2023POU6F2) Hyun-Ju Cho, Fatih Gurbuz, Maria Stamou, Leman Damla Kotan, Stephen Matthew Farmer, Sule Can, Miranda Faith Tompkins, Jamala Mammadova, S. Ayca Altincik, Cumali Gokce, Gonul Catli, Fuat Bugrul, Keenan Bartlett, Ihsan Turan, Ravikumar Balasubramanian, Bilgin Yuksel, Stephanie B. Seminara, Susan Wray, and A. Kemal Topaloglu. Pou6f2 mutation in humans with pubertal failure alters gnrh transcript expression. Frontiers in Endocrinology, August 2023. URL: http://dx.doi.org/10.3389/fendo.2023.1203542, doi:10.3389/fendo.2023.1203542. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fendo.2023.1203542)

[7. (YOSHIDA2014Molecular) Saishu YOSHIDA, Hiroki UEHARU, Masashi HIGUCHI, Kotaro HORIGUCHI, Naoto NISHIMURA, Shiori SHIBUYA, Hideo MITSUISHI, Takako KATO, and Yukio KATO. Molecular cloning of rat and porcine retina-derived pou domain factor 1 (pou6f2) from a pituitary cdna library. Journal of Reproduction and Development, 60(4):288–294, 2014. URL: http://dx.doi.org/10.1262/jrd.2014-023, doi:10.1262/jrd.2014-023. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1262/jrd.2014-023)

[8. (Miao2019Identification) Yazhou Miao, Chuzhong Li, Jing Guo, Hongyun Wang, Lei Gong, Weiyan Xie, and Yazhuo Zhang. Identification of a novel somatic mutation of pou6f2 by whole‐genome sequencing in prolactinoma. Molecular Genetics &amp; Genomic Medicine, November 2019. URL: http://dx.doi.org/10.1002/mgg3.1022, doi:10.1002/mgg3.1022. This article has 11 citations.](https://doi.org/10.1002/mgg3.1022)